1

· 2016-10-11 · ANC < 0.5 X < 10 X 109/L ANC < 1.0 x 50 X 109/1_ ANC 1.0 X 50 X 109/L l) ANC < 0.5 X _ã_e 10 X 109/1_ o#kol kol 01 A-;ol 2. tyrosine LP-OI 0=-ka 01 OHO Bé21(bIast

Download PDF Report

Upload
others
View
30
Download
0

Embed Size (px)

Citation preview

Page 1: · 2016-10-11 · ANC < 0.5 X < 10 X 109/L ANC < 1.0 x 50 X 109/1_ ANC 1.0 X 50 X 109/L l) ANC < 0.5 X _ã_e 10 X 109/1_ o#kol kol 01 A-;ol 2. tyrosine LP-OI 0=-ka 01 OHO Bé21(bIast

BILAG I PRODUKTRESUMÉ · ANC ≥1×109/l Hvis ANC falder, skal næste cyklus afbrydes, indtil ANC ≥1×109/l. Trombocyttallet ≥50×109/la Hvis trombocyttallet falder, ... ASAT/ALAT

BILAG I PRODUKTRESUMÉ · ANC ≥1×109/l Hvis ANC falder, skal næste cyklus afbrydes, indtil ANC ≥1×109/l. Trombocyttallet ≥50×109/la Hvis trombocyttallet falder, ... ASAT/ALAT

Documents

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS€¦ · 30 MU/day (300 μg/day) on 1 - 7 days per week was required to maintain the ANC > 2.0 x 109/l, with the median dose frequency being

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS€¦ · 30 MU/day (300 μg/day) on 1 - 7 days per week was required to maintain the ANC > 2.0 x 109/l, with the median dose frequency being

Documents

ANHANG I ZUSAMMENFASSUNG DER MERKMALE DES …files.homepagemodules.de/b169793/f4t1038p7992n1.pdf · Patienten mit einer ANC von < 0,5 x 109/l oder einer Thrombozytenanzahl von < 50

ANHANG I ZUSAMMENFASSUNG DER MERKMALE DES …files.homepagemodules.de/b169793/f4t1038p7992n1.pdf · Patienten mit einer ANC von < 0,5 x 109/l oder einer Thrombozytenanzahl von < 50

Documents

Antibodies Highlights - Biomol · 2014. 1. 6. · ANC-201 cD50 (human), mab (186-2g9) x x x x x Ms IgG2b x x x ANC-202 cD51 (human), mab (p2w7) x x x x x Ms IgG1κ x x ANC-204 cD53

Antibodies Highlights - Biomol · 2014. 1. 6. · ANC-201 cD50 (human), mab (186-2g9) x x x x x Ms IgG2b x x x ANC-202 cD51 (human), mab (p2w7) x x x x x Ms IgG1κ x x ANC-204 cD53

Documents

Congenital dyserythropoietic anaemiawith unusual ...RBC 3 45 x 1012/1, WBC 7-2 x 109/l (normal differential count), platelets 190 x 109/l, and reti-culocytes I1-%;examinationoftheperipheral

Congenital dyserythropoietic anaemiawith unusual ...RBC 3 45 x 1012/1, WBC 7-2 x 109/l (normal differential count), platelets 190 x 109/l, and reti-culocytes I1-%;examinationoftheperipheral

Documents

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICSe-lactancia.org/media/papers/Tocilizumab-DS-EMA2018.pdf · When ANC increases to > 1 x 109/ l resume RoActemra . ANC < 0.5 Discontinue

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICSe-lactancia.org/media/papers/Tocilizumab-DS-EMA2018.pdf · When ANC increases to > 1 x 109/ l resume RoActemra . ANC < 0.5 Discontinue

Documents

Rapid Vaccine Development & Biomanufacturing Using a ......2 2300 4.8 x 109 8.8 x 107 2.0 x 1011 42 3 2100 7.4 x 109 1.3 x 108 2.7 x 1011 36 Figure 5. Large-scale Lentiviral Vector

Rapid Vaccine Development & Biomanufacturing Using a ......2 2300 4.8 x 109 8.8 x 107 2.0 x 1011 42 3 2100 7.4 x 109 1.3 x 108 2.7 x 1011 36 Figure 5. Large-scale Lentiviral Vector

Documents

ANC-RP Dimensions in Inches - AirConcepts Incairconceptsinc.com/Specifications/ANC-RD-RP-RRBrochure.pdf · ANC-RP Wall/Ceiling Mount ANC-RR Exposed Round Duct ANC-RP Dimensions in

ANC-RP Dimensions in Inches - AirConcepts Incairconceptsinc.com/Specifications/ANC-RD-RP-RRBrochure.pdf · ANC-RP Wall/Ceiling Mount ANC-RR Exposed Round Duct ANC-RP Dimensions in

Documents

Gentra Puregene Handbook - EMMES€¦ · 6 Gentra Puregene Handbook 06/2011 Gentra Puregene Plus Cell Kit (2 x 107) (2 x 108) (8 x 108) (6.7 x 109) (6.7 x 109) Catalog no. 158722

Gentra Puregene Handbook - EMMES€¦ · 6 Gentra Puregene Handbook 06/2011 Gentra Puregene Plus Cell Kit (2 x 107) (2 x 108) (8 x 108) (6.7 x 109) (6.7 x 109) Catalog no. 158722

Documents

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS · ANC return to ≥ 1 x 109/l Resume pomalidomide treatment at 3 mg daily. For each subsequent drop < 0.5 x 109/l Interrupt pomalidomide

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS · ANC return to ≥ 1 x 109/l Resume pomalidomide treatment at 3 mg daily. For each subsequent drop < 0.5 x 109/l Interrupt pomalidomide

Documents

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS · Interrupt Rydapt until ANC ≥1.0 x 109/l, then resume at 50 mg twice daily and, if tolerated, increase to 100 mg twice daily. Discontinue

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS · Interrupt Rydapt until ANC ≥1.0 x 109/l, then resume at 50 mg twice daily and, if tolerated, increase to 100 mg twice daily. Discontinue

Documents

igcsestudybank.weebly.comigcsestudybank.weebly.com/.../0/3/52038731/1993_maths_answers_paper_2.pdf · — 1.5 or IV: 2.70 x 108 + 1.02 x 109 1.29 x 109 using calculator 2.7 Exp 8+

igcsestudybank.weebly.comigcsestudybank.weebly.com/.../0/3/52038731/1993_maths_answers_paper_2.pdf · — 1.5 or IV: 2.70 x 108 + 1.02 x 109 1.29 x 109 using calculator 2.7 Exp 8+

Documents

ANHANG I ZUSAMMENFASSUNG DER MERKMALE DES …ec.europa.eu/health/documents/community-register/2010/2010122094828/... · Patienten mit einer ANC von < 0,5 x 109/l oder einer Thrombozytenanzahl

ANHANG I ZUSAMMENFASSUNG DER MERKMALE DES …ec.europa.eu/health/documents/community-register/2010/2010122094828/... · Patienten mit einer ANC von < 0,5 x 109/l oder einer Thrombozytenanzahl

Documents

Citect 2016 with ANC-100e or ANC- 120e using HMI feature ... · ANC-100e and ANC-120e Ethernet and USB to DH+ Converter Citect 2016 with ANC-100e or ANC-120e using HMI feature and

Citect 2016 with ANC-100e or ANC- 120e using HMI feature ... · ANC-100e and ANC-120e Ethernet and USB to DH+ Converter Citect 2016 with ANC-100e or ANC-120e using HMI feature and

Documents

I. MELLÉKLET ALKALMAZÁSI ELŐÍRÁS · (kezdő adag 100 mg naponta egyszer) ANC < 0,5 × 109/l és/vagy thrombocytaszám < 50 × 109/l 1 A kezelés az alábbi értékek eléréséig

I. MELLÉKLET ALKALMAZÁSI ELŐÍRÁS · (kezdő adag 100 mg naponta egyszer) ANC < 0,5 × 109/l és/vagy thrombocytaszám < 50 × 109/l 1 A kezelés az alábbi értékek eléréséig

Documents

商業簡報網 X matter lab x 109 Free Call Outs Design

商業簡報網 X matter lab x 109 Free Call Outs Design

Education

NEW ZEALAND DATA SHEET - MedsafeANC > 1 Maintain dose ANC 0.5 to 1 Interrupt Actemra dosing For patients receiving intravenous Actemra, when ANC > 1 x 109/L resume Actemra at 4 mg/kg

NEW ZEALAND DATA SHEET - MedsafeANC > 1 Maintain dose ANC 0.5 to 1 Interrupt Actemra dosing For patients receiving intravenous Actemra, when ANC > 1 x 109/L resume Actemra at 4 mg/kg

Documents

F et 01 ,2 ANC 4B - DC Office of Planning · anc 4b anc 6a anc 6b anc 6c anc 6e anc 7d anc 7f anc 4d anc 5a anc 5b anc 5c anc 5d anc 5e 1 2 t h o s t 2 9 t h s s t 4 t h t a v e 5

F et 01 ,2 ANC 4B - DC Office of Planning · anc 4b anc 6a anc 6b anc 6c anc 6e anc 7d anc 7f anc 4d anc 5a anc 5b anc 5c anc 5d anc 5e 1 2 t h o s t 2 9 t h s s t 4 t h t a v e 5

Documents

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS · neutrophil count (ANC) of ≤ 0.5 x 109/L, and a history of severe or recurrent infections, long term administration of Accofil is indicated

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS · neutrophil count (ANC) of ≤ 0.5 x 109/L, and a history of severe or recurrent infections, long term administration of Accofil is indicated

Documents

HIGHLIGHTS OF PRESCRIBING INFORMATION for ICLUSIG · • Interrupt Iclusig and resume at 15 mg after recovery to ANC ≥1.5 x 109/L and platelet ≥75 x 109/L * ANC = absolute neutrophil

HIGHLIGHTS OF PRESCRIBING INFORMATION for ICLUSIG · • Interrupt Iclusig and resume at 15 mg after recovery to ANC ≥1.5 x 109/L and platelet ≥75 x 109/L * ANC = absolute neutrophil

Documents

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS · absolute neutrophil count (ANC) below 2 x 109/l. Laboratory Value (cells x 109/ l ) Action ANC > 1 Maintain dose ANC 0.5 to 1 Interrupt

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS · absolute neutrophil count (ANC) below 2 x 109/l. Laboratory Value (cells x 109/ l ) Action ANC > 1 Maintain dose ANC 0.5 to 1 Interrupt

Documents

Pomp anc Circumstance Parts complete - stallionmusic - …anc... · Pomp anc Circumstance Parts complete.pdf

Pomp anc Circumstance Parts complete - stallionmusic - …anc... · Pomp anc Circumstance Parts complete.pdf

Documents

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS · Withhold Iclusig and resume initial 45 mg dose after recovery to ANC ≥ 1.5 x 109/L and platelet ≥ 75 x 109/L ... (> 2.0 x IULN*)

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS · Withhold Iclusig and resume initial 45 mg dose after recovery to ANC ≥ 1.5 x 109/L and platelet ≥ 75 x 109/L ... (> 2.0 x IULN*)

Documents

Miles 0 0.5 1 - DC Office of Planning...anc 1b anc 1c anc 1d anc 2a anc 2b anc 2c anc 2d anc 4c anc 3e anc 4b anc 2e anc 2f anc 3b anc 3c anc 3d anc 3f anc 3g anc 4a anc 6a anc 6b

Miles 0 0.5 1 - DC Office of Planning...anc 1b anc 1c anc 1d anc 2a anc 2b anc 2c anc 2d anc 4c anc 3e anc 4b anc 2e anc 2f anc 3b anc 3c anc 3d anc 3f anc 3g anc 4a anc 6a anc 6b

Documents

Visions of Life...Near point (m) 3 3 3 4 Field of view m / 1,000 m 117 91 – 70 109 86 Height x Width x Depth (mm) 158 x 135 x 55 155 x 129 x 56 99 x 103 x 44 109 x 108 x 43 Weight

Visions of Life...Near point (m) 3 3 3 4 Field of view m / 1,000 m 117 91 – 70 109 86 Height x Width x Depth (mm) 158 x 135 x 55 155 x 129 x 56 99 x 103 x 44 109 x 108 x 43 Weight

Documents

NEW ZEALAND DATA SHEETANC > 1 Maintain dose ANC 0.5 to 1 Interrupt Actemra dosing For patients receiving intravenous Actemra, when ANC > 1 x 109/L resume Actemra at 4 mg/kg and increase

NEW ZEALAND DATA SHEETANC > 1 Maintain dose ANC 0.5 to 1 Interrupt Actemra dosing For patients receiving intravenous Actemra, when ANC > 1 x 109/L resume Actemra at 4 mg/kg and increase

Documents

¡ NUEVO...Ref. EVSP54 Cubeta bajo encimera. Válvulas de ø 90 mm. (3’5“). Medidas exteriores (mm): 570 L x 450 Anc. x 191 P • cubeta : 520 L x 400 Anc. 570 400 450

¡ NUEVO...Ref. EVSP54 Cubeta bajo encimera. Válvulas de ø 90 mm. (3’5“). Medidas exteriores (mm): 570 L x 450 Anc. x 191 P • cubeta : 520 L x 400 Anc. 570 400 450

Documents

NEW ZEALAND DATA SHEET - Medsafe Home Page · NEW ZEALAND DATA SHEET Actemra 190322 4 Low absolute neutrophil count (ANC) Lab Value (cells x 109/L) Action ANC > 1 Maintain dose ANC

NEW ZEALAND DATA SHEET - Medsafe Home Page · NEW ZEALAND DATA SHEET Actemra 190322 4 Low absolute neutrophil count (ANC) Lab Value (cells x 109/L) Action ANC > 1 Maintain dose ANC

Documents

ILISA RAVIMI OMADUSTE KOKKUVÕTE€¦ · ANC ≥1×109/l Kui ANC langeb, tuleb järgmine ravitsükkel edasi lükata kuni ANC-i taastumiseni väärtusele ≥1×109/l. Trombotsüütide

ILISA RAVIMI OMADUSTE KOKKUVÕTE€¦ · ANC ≥1×109/l Kui ANC langeb, tuleb järgmine ravitsükkel edasi lükata kuni ANC-i taastumiseni väärtusele ≥1×109/l. Trombotsüütide

Documents

A ru-mg-am-109-x

A ru-mg-am-109-x

Documents